Compare the Outcomes of XT and XEC Adjuvant Chemotherapy in HER2-negative Luminal B Breast Cancer Patients
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Sponsor: Guangdong Academy of Medical Sciences
Collaborators: Chinese Anti-Cancer Association|Guangzhou General Hospital of Guangzhou Military Command|Guangzhou First People's Hospital